SG3 Management, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2021$495,000
-21.7%
61,200
-5.1%
0.01%
-47.4%
Q3 2021$632,000
+167.8%
64,513
+84.3%
0.02%
+137.5%
Q2 2021$236,000
-73.9%
35,000
-65.0%
0.01%
-63.6%
Q1 2021$904,000
+659.7%
100,000
+566.7%
0.02%
+37.5%
Q1 2020$119,00015,0000.02%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders